Congruence Therapeutics is a clinical-stage biotechnology company that discovers and develops small molecule correctors and allosteric modulators to ameliorate disease conditions at the molecular level
Congruence Therapeutics is a clinical-stage biotechnology company that discovers and develops small molecule correctors and allosteric modulators to ameliorate disease conditions at the molecular level. They use AI-enabled protein structural information, biology, and chemistry to discover novel small molecules that address disease at its molecular origin.